Schedule 13G ownership disclosure

Innate Pharma SA

Security class unavailable · CUSIP: 45781K105

Event date: 2020-02-03

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
12.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950103-20-001698
Form type
SC 13G
Filer
Innate Pharma SA
CIK
CIK 1598599
Filed
Feb 03, 2020
Reporting period
Feb 03, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub